NCT04834401View on ClinicalTrials.gov

Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

May 17, 2022

Study Completion Date

May 17, 2022

Conditions
Multiple SclerosisCovid19
Trial Locations (1)

07039

Saint Barnabas Medical Center, Livingston

All Listed Sponsors
lead

St. Barnabas Medical Center

OTHER

NCT04834401 - Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis | Biotech Hunter | Biotech Hunter